Pfizer Shrinks Its Drug Pipeline Amid R&D Cuts

In an update Tuesday, Pfizer said it is discontinuing 15 of the projects in its development pipeline. The news comes a month after the world’s largest pharmaceutical company announced large research and development cuts were on…

Novartis Discontinues Two Drug Development Programs

Swiss pharmaceutical company Novartis announced Tuesday that it had discontinued the development of two drugs — the hepatitis C treatment Zalbin, and antifungal agent Mycograb. The company will take impairment charges of appro…